Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2005

Open Access 01-12-2005 | Research

Transhiatal and transthoracic resection in adenocarcinoma of the esophagus: Does the operative approach have an influence on the long-term prognosis?

Authors: Ines Gockel, Sina Heckhoff, Claudia M Messow, Werner Kneist, Theodor Junginger

Published in: World Journal of Surgical Oncology | Issue 1/2005

Login to get access

Abstract

Background

The goal of the present analysis was to investigate the long-term prognosis for adenocarcinoma of the esophagus treated with either the transhiatal (TH) or the transthoracic (TT) operative approach.

Methods

Between September 1985 and March 2004, esophageal resection due to carcinoma was performed on a total of 424 patients. This manuscript takes into account the 150 patients suffering from adenocarcinoma of the esophagus in whom a transhiatal resection of the esophagus was performed. In the event of transmural tumor growth and a justifiable risk of surgery, the transthoracic resection was selected. An extended mediastinal lymph node dissection, however, was only carried out in the course of the transthoracic approach.

Results

The transthoracic resection of the esophagus demonstrated a higher rate of general complications (p = 0.011) as well as a higher mortality rate (p = 0.011). The mediastinal dissection of the lymph nodes, however, revealed no prognostic influence. Considering all of the 150 patients with adenocarcinoma, as well as only those patients who had undergone curative resections (R0), the transhiatal approach was seen to demonstrate a better five-year survival rate of 32.1% versus 35.1%, with a median survival time of 24 versus 28 months, as compared with those who had undergone a transthoracic approach with a five-year survival rate of 13.6% (all patients) versus 17.7% (R0 resection) with a median survival time of 16 versus 17 months (p < 0.05).

Conclusion

The prognosis in patients with adenocarcinoma of the esophagus is influenced by the depth of the tumor (pT) and the pM-category, as shown in the multivariate analysis. The present analysis did not demonstrate a relevant difference in survival for patients with N0 and N1 stages undergoing transhiatal or transthoracic esophagectomy. It is questionable, if a more extensive mediastinal lymph node dissection, in addition to the clearance of abdominal lymph nodes, offers prognostic advantages in adenocarcinoma of the esophagus. However, the morbidity and mortality associated with the transthoracic approach is higher.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hulscher JB, van Sandick JW, de Boer AG, Wijnhoven BP, Tijssen JG, Fockens P, Stalmeier PF, Ten Kate FJ, van Dekken H, Obertop H, Tilanus HW, van Lanschot JJ: Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med. 2002, 347: 1662-1669. 10.1056/NEJMoa022343.CrossRefPubMed Hulscher JB, van Sandick JW, de Boer AG, Wijnhoven BP, Tijssen JG, Fockens P, Stalmeier PF, Ten Kate FJ, van Dekken H, Obertop H, Tilanus HW, van Lanschot JJ: Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med. 2002, 347: 1662-1669. 10.1056/NEJMoa022343.CrossRefPubMed
2.
go back to reference Wittekind CH, Wagner G: TNM-Klassifikation maligner Tumoren. 1997, Springer, Berlin Heidelberg New York, 123-CrossRef Wittekind CH, Wagner G: TNM-Klassifikation maligner Tumoren. 1997, Springer, Berlin Heidelberg New York, 123-CrossRef
3.
go back to reference Orringer MB, Marshall B, Stirling MC: Transhiatal esophagectomy for benign and malignant disease. J Thorac Cardiovasc Surg. 1993, 105: 265-276.PubMed Orringer MB, Marshall B, Stirling MC: Transhiatal esophagectomy for benign and malignant disease. J Thorac Cardiovasc Surg. 1993, 105: 265-276.PubMed
4.
go back to reference Pac M, Basoglu A, Kocak H, Yekeler I, Yediyildiz S, Aydin NE, Yilm A, Okcu N, Keles M: Transhiatal versus transthoracic esophagectomy for esophageal cancer. J Thorac Cardiovasc Surg. 1993, 106: 205-209.PubMed Pac M, Basoglu A, Kocak H, Yekeler I, Yediyildiz S, Aydin NE, Yilm A, Okcu N, Keles M: Transhiatal versus transthoracic esophagectomy for esophageal cancer. J Thorac Cardiovasc Surg. 1993, 106: 205-209.PubMed
5.
go back to reference Fok M, Siu KF, Wong J: A comparison of transhiatal and transthoracic resection for carcinoma of the thoracic esophagus. Am J Surg. 1989, 158: 414-419. 10.1016/0002-9610(89)90275-4.CrossRefPubMed Fok M, Siu KF, Wong J: A comparison of transhiatal and transthoracic resection for carcinoma of the thoracic esophagus. Am J Surg. 1989, 158: 414-419. 10.1016/0002-9610(89)90275-4.CrossRefPubMed
6.
go back to reference Boyle MJ, Franceschi D, Livingstone AS: Transhiatal versus transthoracic esophagectomy: complication and survival rates. Am Surg. 1999, 65: 1137-1141.PubMed Boyle MJ, Franceschi D, Livingstone AS: Transhiatal versus transthoracic esophagectomy: complication and survival rates. Am Surg. 1999, 65: 1137-1141.PubMed
7.
go back to reference Müller JM, Erasmi H, Stelzner M, Zieren U, Pichlmaier H: Surgical therapy of esophageal carcinoma. Br J Surg. 1990, 77: 845-857.CrossRefPubMed Müller JM, Erasmi H, Stelzner M, Zieren U, Pichlmaier H: Surgical therapy of esophageal carcinoma. Br J Surg. 1990, 77: 845-857.CrossRefPubMed
8.
go back to reference Chu KM, Law SY, Fok M, Wong J: A prospective randomized comparison of transhiatal and transthoracic resection for lower-third esophageal carcinoma. Am J Surg. 1997, 174: 320-324. 10.1016/S0002-9610(97)00105-0.CrossRefPubMed Chu KM, Law SY, Fok M, Wong J: A prospective randomized comparison of transhiatal and transthoracic resection for lower-third esophageal carcinoma. Am J Surg. 1997, 174: 320-324. 10.1016/S0002-9610(97)00105-0.CrossRefPubMed
9.
go back to reference Goldminc M, Maddern G, Le Prise E, Meunier B, Campion JP, Launois B: Oesophagectomy by transhiatal approach or thoracotomy: a prospective randomized trial. Br J Surg. 1993, 80: 367-370.CrossRefPubMed Goldminc M, Maddern G, Le Prise E, Meunier B, Campion JP, Launois B: Oesophagectomy by transhiatal approach or thoracotomy: a prospective randomized trial. Br J Surg. 1993, 80: 367-370.CrossRefPubMed
10.
go back to reference Jacobi CA, Zieren HU, Müller JM, Pichlmaier H: Surgical therapy of esophageal carcinoma: the influence of surgical approach and esophageal resection on cardiopulmonary function. Eur J Cardiothorac Surg. 1997, 11: 32-37. 10.1016/S1010-7940(96)01106-2.CrossRefPubMed Jacobi CA, Zieren HU, Müller JM, Pichlmaier H: Surgical therapy of esophageal carcinoma: the influence of surgical approach and esophageal resection on cardiopulmonary function. Eur J Cardiothorac Surg. 1997, 11: 32-37. 10.1016/S1010-7940(96)01106-2.CrossRefPubMed
11.
go back to reference Hulscher JBF, Tijssen JGP, Obertop H, van Lanschot JJB: Transthoracic versus transhiatal resection for carcinoma of the esophagus: a meta-analysis. Ann Thorac Surg. 2001, 72: 306-313. 10.1016/S0003-4975(00)02570-4.CrossRefPubMed Hulscher JBF, Tijssen JGP, Obertop H, van Lanschot JJB: Transthoracic versus transhiatal resection for carcinoma of the esophagus: a meta-analysis. Ann Thorac Surg. 2001, 72: 306-313. 10.1016/S0003-4975(00)02570-4.CrossRefPubMed
12.
13.
go back to reference Roder JD, Busch R, Stein HJ, Fink U, Siewert JR: Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus. Br J Surg. 1994, 81: 410-413.CrossRefPubMed Roder JD, Busch R, Stein HJ, Fink U, Siewert JR: Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus. Br J Surg. 1994, 81: 410-413.CrossRefPubMed
14.
go back to reference Siewert JR, Stein HJ: Lymph node dissection in squamous cell esophageal cancer – who benefits?. Langenbecks Arch Surg. 1999, 384: 141-148. 10.1007/s004230050184.CrossRefPubMed Siewert JR, Stein HJ: Lymph node dissection in squamous cell esophageal cancer – who benefits?. Langenbecks Arch Surg. 1999, 384: 141-148. 10.1007/s004230050184.CrossRefPubMed
15.
go back to reference Tsurumaru M, Kajiyama Y, Udagawa H, Akiyama H: Outcomes of extended lymph node dissection for squamous cell carcinoma of the thoracic esophagus. Ann Thorac Cardiovasc Surg. 2001, 7: 325-329.PubMed Tsurumaru M, Kajiyama Y, Udagawa H, Akiyama H: Outcomes of extended lymph node dissection for squamous cell carcinoma of the thoracic esophagus. Ann Thorac Cardiovasc Surg. 2001, 7: 325-329.PubMed
16.
go back to reference Tachimori Y, Kato H, Watanabe H, Sasako M, Kinoshita T, Maruyama K: Difference between carcinoma of the lower esophagus and the cardia. World J Surg. 1996, 20: 507-510. 10.1007/s002689900080.CrossRefPubMed Tachimori Y, Kato H, Watanabe H, Sasako M, Kinoshita T, Maruyama K: Difference between carcinoma of the lower esophagus and the cardia. World J Surg. 1996, 20: 507-510. 10.1007/s002689900080.CrossRefPubMed
17.
go back to reference Van de Ven C, De Leyn P, Coosemans W, Van Raemdonck D, Lerut T: Three-field lymphadenectomy and pattern of lymph node spread in T3 adenocarcinoma of the distal esophagus and the gastro-esophageal junction. Eur J Cardiothorac Surg. 1999, 15: 769-773. 10.1016/S1010-7940(99)00122-0.CrossRefPubMed Van de Ven C, De Leyn P, Coosemans W, Van Raemdonck D, Lerut T: Three-field lymphadenectomy and pattern of lymph node spread in T3 adenocarcinoma of the distal esophagus and the gastro-esophageal junction. Eur J Cardiothorac Surg. 1999, 15: 769-773. 10.1016/S1010-7940(99)00122-0.CrossRefPubMed
18.
go back to reference Medical Research Council Oesophageal Cancer Working Group: Surgical resection with or without preoperative chemotherapy in esophageal cancer. A randomized controlled trial. Lancet. 2002, 359: 1727-1733. 10.1016/S0140-6736(02)08651-8.CrossRef Medical Research Council Oesophageal Cancer Working Group: Surgical resection with or without preoperative chemotherapy in esophageal cancer. A randomized controlled trial. Lancet. 2002, 359: 1727-1733. 10.1016/S0140-6736(02)08651-8.CrossRef
19.
go back to reference Samel S, Hofheinz R, Hundt A, Sturm J, Knoll MR, Wenz F, Queißer W, Post S: Neoadjuvant radio-chemotherapy of adenocarcinoma of the oesophagogastric junction. Onkologie. 2001, 24: 278-282. 10.1159/000055092.CrossRefPubMed Samel S, Hofheinz R, Hundt A, Sturm J, Knoll MR, Wenz F, Queißer W, Post S: Neoadjuvant radio-chemotherapy of adenocarcinoma of the oesophagogastric junction. Onkologie. 2001, 24: 278-282. 10.1159/000055092.CrossRefPubMed
Metadata
Title
Transhiatal and transthoracic resection in adenocarcinoma of the esophagus: Does the operative approach have an influence on the long-term prognosis?
Authors
Ines Gockel
Sina Heckhoff
Claudia M Messow
Werner Kneist
Theodor Junginger
Publication date
01-12-2005
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2005
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-3-40

Other articles of this Issue 1/2005

World Journal of Surgical Oncology 1/2005 Go to the issue